predictors of long-term survival in patients with dlbcl/hgbcl following autosct
Published 1 year ago • 187 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
1:57
combining molecular and clinical data to predict survival & transformation risk in patients with mds
-
0:59
developing lsc-targeting agents in aml: progress and current therapeutic capacity
-
3:30
clinical value of event-free survival in aml
-
6:16
the challenge of survivorship in aml
-
14:25
an overview of novel innovative treatments for patients with von willebrand disease
-
3:40
results of a study evaluating the predictive power of fish markers for pfs in al amyloidosis
-
1:39
managing early & late relapse after first-line therapy for dlbcl
-
0:39
selecting patients with scd for allosct
-
1:39
update on a phase i/ii study of ziftomenib in patients with r/r aml
-
5:08
using real-world data to understand the survival and engraftment of stem cells after allosct
-
2:41
cell avidity as a predictor of t-cell efficacy
-
2:38
car-t therapy for aggressive b-cell lymphomas
-
2:38
zuma-1 & scholar-1: comparison of outcomes in refractory dlbcl
-
2:53
autohct in dlbcl in the car-t era
-
1:02
maintenance therapy following treatment for amyloidosis
-
1:36
relative dose intensity in older dlbcl patients
-
3:53
standard-of-care setting results of axi-cel in r/r large b-cell lymphoma
-
1:51
thrombotic and bleeding complications in al amyloidosis